QIAGEN NV (QGEN)
55.50
+0.05
(+0.09%)
USD |
NYSE |
Jan 21, 15:56
QIAGEN Market Cap: 11.43B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InflaRx NV | 67.75M |
| CDT Equity, Inc. | 2.330M |
| LENZ Therapeutics, Inc. | 609.53M |
| Liminatus Pharma, Inc. | 18.98M |
| Oruka Therapeutics, Inc. | 1.673B |
Market Cap Related Metrics
| PE Ratio | 28.44 |
| PS Ratio | 5.569 |
| PEG Ratio | 0.0743 |
| Price to Book Value | 3.133 |
| Price to Free Cash Flow | 24.41 |
| Price | 55.50 |
| Earnings Yield | 3.52% |
| PEGY Ratio | 0.0729 |
| Operating PE Ratio | 21.19 |
| Normalized PE Ratio | 25.59 |